April 26–29, 2009
Gaylord Texan Resort
Dallas, Texas
www.sawc.net

The following Exhibitor Preview highlights some of the companies, products, and services that will be showcased during the upcoming Symposium on Advanced Wound Care and Wound Healing Society Meeting (SAWC/WHS). Each exhibitor represents a valuable resource for learning, and provides an enjoyable way to meet the professionals who bring these products and services to you. Be sure to take the opportunity to see what they have in store for you in the SAWC/WHS 2009 Exhibit Hall at the Gaylord Texan Resort and Convention Center.

Andover Healthcare, Inc. – Booth #1031

     Andover Healthcare, Inc. has been a leading manufacturer of bandages and tapes for more than 30 years and currently supplies the healthcare, sports medicine, and animal health industries with high quality products made in the USA. Founded in 1976, Andover is committed to new and innovative technology and distributes its patented products around the world. Andover was first to develop a truly cohesive latex-free bandage and first to offer cohesive bandages with controlled compression. Additionally, Andover was first to introduce colors, first to offer a color pack, and is the exclusive manufacturer of latex-free prints.

Arobella Medical, LLC – Booth #931

     Arobella Medical, LLC (Minnetonka, Minn) is a medical device company specializing in low-frequency, cavitational ultrasound for wound care and wound management therapies. The company is committed to providing wound care professionals with pioneering technology to manage today’s most difficult cases. Arobella Medical, LLC co-founder and CEO Eliaz Babaev has more than 45 years of experience developing, designing, and launching medical devices that use ultrasound. The Qoustic Wound Therapy System™, our newest product, advances debridement by delivering focused ultrasonic energy from the proprietary Qoustic Qurette™ as it lightly contacts the wound bed, gently separating and removing unwanted tissue while preserving healthy granulation tissue. It is also useful in preparing the wound bed for other therapies, such as grafts and flaps. The Qoustic Wound Therapy System is portable and can be used in many healthcare settings. Arobella Medical, LLC is the leader in advanced ultrasound wound care. For more information, visit www.arobella.com.

Care Tech Laboratories, Inc. – Booth #901

     CARE-TECH® is the innovator of non-toxic, broad-spectrum antiseptic technology for the prevention and/or treatment of topical infection. Products cover a wide range of skin maladies including wound therapy, bariatric and diabetic skin as well as surgical site infection. MRSA effective!

Celleration, Inc. – Booth #717

     MIST Therapy® is an innovative, non-contact approach to wound healing. The MIST system creates low-frequency ultrasound waves that produce and propel a gentle mist of sterile saline into the wound bed. This advanced bioactive therapy promotes painless, accelerated healing through cellular stimulation while reducing bioburden. Clinically proven for modern wound care.

ConvaTec – Booth #501

     ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With 4 key business divisions—Ostomy Care, Wound Therapeutics, Continence, and Critical Care and Infusion Devices—ConvaTec products support health care professionals from the hospital to the community health setting. From its headquarters in Skillman, NJ, the company oversees more than 8,000 employees in over 90 countries serving consumers and their health care professionals on 6 continents.

Cytomedix – Booth #729

     Cytomedix, Inc. is a biotechnology company developing advanced tissue regeneration technologies including products to fight inflammation and initiate angiogenesis. Our primary focus is the utilization of platelets and platelet derivatives to manage wound healing, improving the lives of patients suffering with chronic wounds.

     The AutoloGel™ System is the only FDA cleared platelet-rich plasma (PRP) system designed for use in chronic wounds. From a small amount of patients blood we separate the platelet rich plasma in a proprietary process that releases multiple growth factors, cytokines and chemokines. When applied to the prepared wound bed, AutoloGel restores the delicate balance missing from chronic wounds and allows the natural healing process to take place. The AutoloGel System is indicated for exuding wounds, such as leg ulcers, pressure ulcers, and diabetic ulcers, and for the management of mechanically and surgically debrided wounds.

     The effectiveness of the AutoloGel System is documented in a prospective, randomized, controlled study of patients with diabetic foot ulcers. The endpoint of the study was complete wound closure maintained for at least 12 weeks of follow up. In our study, AutoloGel demonstrated significance in outcomes versus an active control agent. Additionally, we have recently conducted an economic analysis to document cost effectiveness and patient quality of life with the AutoloGel System.

     Cytomedix clinical staff and account managers will provide your care setting with the training, support, and certification to efficiently manage challenging wounds in 15 minutes or less using the AutoloGel System. Let us help you establish AutoloGel in your wound care protocol and begin restoring the balance.

Derma Sciences, Inc. – Booth #323

     Derma Sciences, Inc. is a full line supplier of advanced and traditional wound care products. In the 1980s, our Dermagran® line of skin protectants became a leading brand for the use of zinc and other micronutrients delivered topically for pressure ulcer management. This innovation has continued with the recent launch of our Medihoney® line — various dressings that include Leptospermum (Manuka) honey.
     Strong evidence supports use of these dressings on stalled wounds, particularly venous leg ulcers that have failed to progress with first line therapy. Additional new products to our line include Xtrasorb™, a highly absorptive dressing that utilizes a super-absorbent polymer core to not only absorb more fluid than traditional dressings such as foams and ABD pads, but also locks that fluid into a gel within the core of the dressing. MOBILITY1™ is another newly launched product — it is the first and only fully sequential and gradient intermittent pneumatic compression therapy device for ambulatory patients. Indicated for the treatment of CVI, venous leg ulcers, lymphedema, postoperative pain, and for the prevention of DVT, this device does not require an external electronic compressor. As such, it allows mobile patients to enjoy a more normal lifestyle, and reduces missed days of work associated with typical IPC therapy.

     Our goal is to help caregivers provide optimal care to their patients through the use of novel, cost-effective technologies. Visit www.dermasciences.com for more information.

Healthpoint, Ltd. – Booth #411

     HEALTHPOINT is committed to the research, development and marketing of branded biologics, pharmaceuticals and medical devices for the prevention and treatment of diseased and traumatized skin and related soft tissue. HEALTHPOINT products include: Collagenase SANTYL® Ointment, OASIS® Wound Matrix, and Hydrofera Blue™ Bacteriostatic Wound Dressings. HEALTHPOINT is a DFB Pharmaceuticals, Inc. affiliate company. For more information, visit www.healthpoint.com, call us at (800) 441-8227, or visit our booth.

Organogenesis, Inc. – Booth #209

     Organogenesis, Inc. (Canton, Mass) is a world leading regenerative medicine company focused in the areas of bio-active wound healing and bio-surgery. Organogenesis delivers living tissue “on demand,” and its mission is to bring the medical marvel of regenerative medicine products to patients and to standardize their use in everyday medical care. Apligraf®, the company’s flagship product, is the first and only fully differentiated living bi-layered cell based product that has FDA approval for the treatment of venous leg ulcers and diabetic foot ulcers. When placed on a wound previously unresponsive to treatment, Apligraf plays an active role by providing cells and proteins that help promote healing. Apligraf is easy to incorporate into practice. Positive reimbursement in all settings. Apligraf has been used to treat many thousands of patients. Visit www.organogenesis.com or www.apligraf.com for more information.

Smith & Nephew Wound Management – Booth #401

     In 2009, Smith & Nephew continues to support the clinical judgment of wound care specialists with a growing portfolio of innovative products, including ALLEVYN™ Gentle and ALLEVYN™ Gentle Border, ACTICOAT™ Flex, and RENASYS™ Negative Pressure Wound Therapy.

     The RENASYS EZ and RENASYS GO systems for in-facility and portable use, respectively, are based on customer insights to improve the NPWT experience, focusing on greater ease-of-use and patient comfort across the full range of wound types. The RENASYS EZ allows clinicians to use variable pressure control, enables clinicians to treat surgical, traumatic, or chronic wounds according to the individual needs of the patient and the characteristics of the patient’s wound. The RENASYS GO is a sleek, quiet, and comfortable device that provides a seamless transition from inpatient to outpatient care. Both systems can be used with both the foam and gauze wound interfaces, allowing for broader therapy selection from a single supplier.

     With more than 150 years of experience in wound care, Smith & Nephew is the innovative leader providing a range of solutions to meet the needs of chronic, acute, and traumatic wounds.

     ™Trademark of Smith & Nephew. Certain marks registered US Patent and Trademark Office.

Systagenix Wound Management – Booth #523

     Systagenix Wound Management, formerly the Professional Wound Care Business of Ethicon Inc., a Johnson & Johnson Company, is focused on achieving further success in providing evidence-based solutions that will enhance the treatment of wounds whilst building on its current portfolio of internationally renowned advanced and general wound care products. These include such innovative brands such as PROMOGRAN® Matrix Wound Dressing, PRISMA® Matrix, SILVERCEL® Antimicrobial Alginate dressing and REGRANEX® (becaplermin) Gel 0.01%.

ULURU, Inc. – Booth #245

     Altrazeal™, a transforming powder dressing, which is produced using our Nanoflex™ Technology, is a breakthrough new treatment for exuding wounds including burns, trauma, skin graft donor sites, surgical wounds and chronic slow-healing wounds such as diabetic foot ulcers, pressure ulcers and venous ulcers. Altrazeal is designed for greater effectiveness in wound closure by promoting an optimal moist wound healing environment. Altrazeal provides additional patient benefits including reduced pain and enhanced patient comfort, ease of application and removal and, in most cases, it does not require a secondary dressing. Please visit our website www.altrazeal.com for more information.

     ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management, plastic surgery and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative transmucosal delivery system and Nanoflex Aggregate technology. Please visit our website www.uluruinc.com for more information.